genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Cellectis Details Proof-of-Concept for “Smart” CAR T-Cells
Neuroscience
Merck Acquires TRPML1 Agonist Developer Calporta for Up to $576M
News
Rentschler Begins its Facility Expansion in the Boston Biotech Hub
Bioprocessing
Avantor and NIBRT Agree to Jointly Address Downstream Bottlenecks
Bioprocessing
Data Analytics to Become “Central Pillar” of Biomanufacturing
Insights
Insights
How to Use CRISPR for Site-Specific Epigenetic Editing in the Nervous…
Bioprocessing
The Balance of Bioprocess Models
Insights
A Roadmap and Wish List for Synthetic Genomics
Insights
Improving Integrated Clinical Trial Management Systems through Blockchain
November 2019 Vol. 39 No. 11
Synthetic Biology Seizes New Ground in Healthcare
A-Lists
A-Lists
Top 25 Biotech Companies of 2019
Insights
Top 10 Asia Biopharma Clusters 2019
Brexit
Top 10 European Biopharma Clusters
GEN Edge
Top 10 U.S. Biopharma Clusters
Insights
10 Takeover Targets to Watch This Fall
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Insights
How to Use CRISPR for Site-Specific Epigenetic Editing in the Nervous…
News
Cellectis Details Proof-of-Concept for “Smart” CAR T-Cells
Bioprocessing
Avantor and NIBRT Agree to Jointly Address Downstream Bottlenecks
Bioprocessing
The Balance of Bioprocess Models
Magazine
November 2019 Vol. 39 No. 11
Cold Block
November 2019 Vol. 39 No. 11
Next-Generation Centrifuge
November 2019 Vol. 39 No. 11
Synthetic Biology Seizes New Ground in Healthcare
November 2019 Vol. 39 No. 11
Agrigenomics Yields a Next-Gen Cornucopia
November 2019 Vol. 39 No. 11
Protein-Protein Interactions Get a New Groove On
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
Smarter Biobank Management
Upcoming Webinars
An Automated Solution for Single-Cell Gene Expression Workflows
November 2019 Vol. 39 No. 11
Cold Block
November 2019 Vol. 39 No. 11
Next-Generation Centrifuge
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Cancer
Multiple Myeloma
Multiple Myeloma
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Multiple Myeloma
Allogene, Notch Partner to Develop iPSC-Derived Blood Cancer Therapies
Multiple Myeloma
Amgen Expands China Presence, Cancer R&D with $2.7B BeiGene Collaboration
Multiple Myeloma
Janssen, Genmab Partner on Follow-On to Darzalex for Multiple Myeloma, Diffuse Large B-Cell Lymphoma
Multiple Myeloma
AbbVie to Co-Develop Teneobio’s Lead Candidate for Multiple Myeloma, Gains Acquisition Option
Multiple Myeloma
DNA/RNA Sequencing Offers Hope to Drug-Resistant Multiple Myeloma Patients
Multiple Myeloma
Patient Deaths Cited as Darzalex Combination Trials Halted
Multiple Myeloma
MorphoSys to Advance Pipeline, Platform Through Up-to-$150M U.S. IPO
Multiple Myeloma
Multiple Myeloma Patient Survival Associated with ADAR1 Enzyme Levels
Multiple Myeloma
A Cancer Cell’s Weight Predicts Its Therapeutic Opponent
Multiple Myeloma
Kite Pharma Submits IND for BCMA-Targeting CAR-T Cancer Immunotherapy
Multiple Myeloma
Janssen, Adaptive to Develop clonoSEQ for Measuring MRD in Darzalex-Treated MM
Multiple Myeloma
Liquid Biopsies Provide Patients with Less Painful Test for Multiple Myeloma
Multiple Myeloma
Stopping Myeloma in Its Tracks
Multiple Myeloma
A Mapping Service for the Cancer Genome
Multiple Myeloma
MorphoSys Regains MOR202 Rights as Celgene Collaboration Ends
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Human myeloma cells grown in a bone marrow-like microenvironment. [UC San Diego Health]](https://www.genengnews.com/wp-content/uploads/2018/08/Dec6_2017_UCSDHealth_MyelomaCells8067232147-324x160.jpg "Multiple Myeloma Patient Survival Associated with ADAR1 Enzyme Levels")
![Researchers developed a RNA and DNA sequencing platform that benefits late-stage and drug-resistant multiple myeloma patients. [UCSF/Getty Images]](https://www.genengnews.com/wp-content/uploads/2018/08/Aug9_2018_Getty_507828431_MultipleMyeloma_6001086401541-265x198.jpg "DNA/RNA Sequencing Offers Hope to Drug-Resistant Multiple Myeloma Patients")
